Three days with the founders, biopharma leaders, and the investors building the future of biology.
Three days with the founders, biopharma leaders, and the investors building the future of biology.
We are the premier gathering of frontier biology founders, investors, decision makers & explorers.
We are the premier gathering of frontier biology founders, investors, decision makers, & explorers.
SynBioBeta 2026. May 4-7, San Jose, California
Who should attend?
SynBioBeta is for the people building with biology and the people funding, buying, and partnering with them. If you're a founder raising capital, a company looking for your next technology partner or customer, or a team tracking how AI is reshaping your industry, the people you want to meet are here for three days.
Why attend?
The startups presenting at SynBioBeta this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and sweet proteins that replace sugar. They're on stage alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Unilever, and P&G. Watching how these companies interact, where the partnerships form, and which technologies the biggest players are evaluating is something you can't get from a report or webinar. And our 1:1 Partnering App lets you book meetings before you arrive.
Founders on Stage
Funders Writing Checks
Partners on Stage
Who’s Coming to SynBioBeta?
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
Eric Schmidt
Former CEO
"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."
Celestine Schnugg
Founder
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
Surge Biswas
Founder
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
Jacob Glanville
Founder & CEO
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
Bill Tai
Co-founder
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
Luis Cascao-Pereira
Head of Digital Biology
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
Ola Wlodek
CEO
Join for the latest
SynBioBeta event updates.